Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Recipharm Expands API Manufacturing Capabilities | Contract Pharma

What are you searching for?

Sign in
Breaking News

Recipharm Expands API Manufacturing Capabilities

Invests $2.5 million in clinical GMP capacity for APIs at Israel facility.

By: Contract Pharma

Contract Pharma Staff

Global contract development and manufacturing organization (CDMO), Recipharm, has unveiled an investment and capacity expansion at its facility in Israel. This investment will support customers’ growing demand for cGMP clinical supply of active pharma ingredients (API) and intermediates and is part of an integrated plan to enhance Recipharm’s offering in drug substances services.
 
The investment will see the implementation of a full GMP chemical unit including a number of brand-new R&D laboratories and technologies. This will allow Recipharm to support customers through their development projects, from early medicinal chemistry into commercialization, through a single integrated flow. The expansion is expected to be fully operative by the end of 2021.
 
“Recipharm is proud to making this investment. It will be unique in Israel, where we have a talented team who excel at bringing customers molecules to life,” said Bernard Pluta, president development services, Recipharm. “Complementing our API development and manufacturing facilities in Europe, the investment provides our customers with a reliable value chain of quality APIs; which will ultimately benefit patients.”
 
Recipharm’s facility in Israel is located south of Tel Aviv in the vicinity of the Weizmann Science Park. The team specializes in medicinal chemistry. The offering includes a wide array of services in chemical synthesis and analysis including some very demanding and novel specialties. The company also offers analytical and pre-clinical services.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics